Erik Pacyniak

732 total citations
23 papers, 600 citations indexed

About

Erik Pacyniak is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Erik Pacyniak has authored 23 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Virology, 11 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Erik Pacyniak's work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (10 papers) and Herpesvirus Infections and Treatments (4 papers). Erik Pacyniak is often cited by papers focused on HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (10 papers) and Herpesvirus Infections and Treatments (4 papers). Erik Pacyniak collaborates with scholars based in United States and Cameroon. Erik Pacyniak's co-authors include Edward B. Stephens, Grace L. Guo, David R. Hout, Curtis D. Klaassen, Michael L. Cunningham, Xingguo Cheng, Kevin M. Crofton, David M. Pinson, Scott W. Wong and Dinesh Kumar Singh and has published in prestigious journals such as Virology, Journal of Pharmaceutical Sciences and Toxicology and Applied Pharmacology.

In The Last Decade

Erik Pacyniak

23 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik Pacyniak United States	16	330	158	147	139	127	23	600
Karen Davis‐Bruno United States	12	180 0.5×	108 0.7×	29 0.2×	149 1.1×	54 0.4×	19	545
Yun Lan Yueh United States	8	108 0.3×	144 0.9×	59 0.4×	62 0.4×	40 0.3×	10	384
Dale M. Walker United States	18	128 0.4×	209 1.3×	61 0.4×	275 2.0×	103 0.8×	37	771
Quanxin Meng United States	18	87 0.3×	149 0.9×	57 0.4×	316 2.3×	136 1.1×	25	683
Vipul K. Singh United States	16	32 0.1×	254 1.6×	184 1.3×	155 1.1×	95 0.7×	40	708
Louise Hansen Denmark	13	81 0.2×	42 0.3×	51 0.3×	158 1.1×	25 0.2×	17	592
Ping Ruan United States	14	121 0.4×	161 1.0×	177 1.2×	145 1.0×	5 0.0×	25	557
Laurie A. VanderVeen United States	9	167 0.5×	185 1.2×	40 0.3×	186 1.3×	19 0.1×	23	435
Daryl C. Thake United States	11	31 0.1×	59 0.4×	67 0.5×	75 0.5×	85 0.7×	19	488
Isabel Zeitträger Germany	9	41 0.1×	36 0.2×	146 1.0×	128 0.9×	20 0.2×	9	401

Countries citing papers authored by Erik Pacyniak

Since Specialization

Citations

This map shows the geographic impact of Erik Pacyniak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Pacyniak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Pacyniak more than expected).

Fields of papers citing papers by Erik Pacyniak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Pacyniak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Pacyniak. The network helps show where Erik Pacyniak may publish in the future.

Co-authorship network of co-authors of Erik Pacyniak

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Pacyniak. A scholar is included among the top collaborators of Erik Pacyniak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Pacyniak. Erik Pacyniak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huckle, James E., Matthew P. Sadgrove, Erik Pacyniak, et al.. (2015). Orally administered DTPA di-ethyl ester for decorporation of²⁴¹Am in dogs: Assessment of safety and efficacy in an inhalation-contamination model. International Journal of Radiation Biology. 91(7). 568–575. 13 indexed citations

Fu, Jing, et al.. (2015). Interspecies Differences in the Metabolism of a Multiester Prodrug by Carboxylesterases. Journal of Pharmaceutical Sciences. 105(2). 989–995. 18 indexed citations

Zhang, Yong, Matthew P. Sadgrove, Erik Pacyniak, et al.. (2013). Nonaqueous Gel for the Transdermal Delivery of a DTPA Penta-ethyl Ester Prodrug. The AAPS Journal. 15(2). 523–532. 16 indexed citations

Pacyniak, Erik, Bruno Hagenbuch, Curtis D. Klaassen, Lois D. Lehman‐McKeeman, & Grace L. Guo. (2011). Organic anion transporting polypeptides in the hepatic uptake of PBDE congeners in mice. Toxicology and Applied Pharmacology. 257(1). 23–31. 8 indexed citations

Pacyniak, Erik, Megan Roth, Bruno Hagenbuch, & Grace L. Guo. (2010). Mechanism of Polybrominated Diphenyl Ether Uptake into the Liver: PBDE Congeners Are Substrates of Human Hepatic OATP Transporters. Toxicological Sciences. 115(2). 344–353. 36 indexed citations

Ruiz, Autumn, et al.. (2007). Modulation of the severe CD4+ T-cell loss caused by a pathogenic simian–human immunodeficiency virus by replacement of the subtype B vpu with the vpu from a subtype C HIV-1 clinical isolate. Virology. 371(1). 86–97. 20 indexed citations

Pacyniak, Erik, Xingguo Cheng, Michael L. Cunningham, et al.. (2007). The Flame Retardants, Polybrominated Diphenyl Ethers, Are Pregnane X Receptor Activators. Toxicological Sciences. 97(1). 94–102. 123 indexed citations

Pacyniak, Erik, et al.. (2006). APOBEC3G Expression Is Restricted to Neurons in the Brains of Pigtailed Macaques. AIDS Research and Human Retroviruses. 22(6). 541–550. 15 indexed citations

Hout, David R., et al.. (2006). A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian–human immunodeficiency virus (SHIVKU-1bMC33) susceptible to rimantadine. Virology. 348(2). 449–461. 31 indexed citations

10.

Pacyniak, Erik, et al.. (2005). Identification of a Region within the Cytoplasmic Domain of the Subtype B Vpu Protein of Human Immunodeficiency Virus Type 1 (HIV-1) That Is Responsible for Retention in the Golgi Complex and Its Absence in the Vpu Protein from a Subtype C HIV-1. AIDS Research and Human Retroviruses. 21(5). 379–394. 52 indexed citations

11.

Hout, David R., Erik Pacyniak, David M. Pinson, et al.. (2005). Scrambling of the amino acids within the transmembrane domain of Vpu results in a simian-human immunodeficiency virus (SHIVTM) that is less pathogenic for pig-tailed macaques. Virology. 339(1). 56–69. 36 indexed citations

12.

Hout, David R., Erik Pacyniak, Barbara Fegley, et al.. (2005). Substitution of the transmembrane domain of Vpu in simian–human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques. Virology. 344(2). 541–559. 31 indexed citations

13.

Hout, David R., Erik Pacyniak, Barbara Fegley, et al.. (2004). Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIVKU-1bMC33) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques. Virology. 323(1). 91–107. 4 indexed citations

14.

Stephens, Edward B., et al.. (2003). The Primary Phase of Infection by Pathogenic Simian–Human Immunodeficiency Virus Results in Disruption of the Blood–Brain Barrier. AIDS Research and Human Retroviruses. 19(10). 837–846. 14 indexed citations

15.

Singh, Dinesh Kumar, Darcy M. Griffin, Erik Pacyniak, et al.. (2003). The presence of the casein kinase II phosphorylation sites of Vpu enhances the CD4+ T cell loss caused by the simian–human immunodeficiency virus SHIVKU-lbMC33 in pig-tailed macaques. Virology. 313(2). 435–451. 29 indexed citations

16.

Singh, Dinesh Kumar, et al.. (2003). Infection of human astrocytoma cells with simian-human immunodeficiency virus results in up-regulation of gene expression and altered growth properties. Neuroscience Letters. 340(3). 201–204. 2 indexed citations

17.

Stephens, Edward B., Erik Pacyniak, Darcy M. Griffin, et al.. (2002). Deletion of the vpu Sequences prior to the env in a Simian–Human Immunodeficiency Virus Results in Enhanced Env Precursor Synthesis but Is Less Pathogenic for Pig-Tailed Macaques. Virology. 293(2). 252–261. 55 indexed citations

18.

Singh, Dinesh Kumar, Erik Pacyniak, Darcy M. Griffin, et al.. (2002). Pathogenic and Nef-Interrupted Simian–Human Immunodeficiency Viruses Traffic to the Macaque CNS and Cause Astrocytosis Early after Inoculation. Virology. 296(1). 39–51. 18 indexed citations

19.

Stephens, Edward B., et al.. (2001). Comparison of Vif Sequences from Diverse Geographical Isolates of HIV Type 1 and SIV _cpz Identifies Substitutions Common to Subtype C Isolates and Extensive Variation in a Proposed Nuclear Transport Inhibition Signal. AIDS Research and Human Retroviruses. 17(2). 169–177. 11 indexed citations

20.

Singh, Dinesh Kumar, Erik Pacyniak, Francis Sun, et al.. (2001). A Simian Human Immunodeficiency Virus with a Nonfunctional Vpu (ΔvpuSHIVKU-1bMC33) Isolated from a Macaque with NeuroAIDS Has Selected for Mutations in Env and Nef That Contributed to Its Pathogenic Phenotype. Virology. 282(1). 123–140. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact